KLEO
Kleo is developing two types of small molecules to treat cancer, infectious diseases, and a broad range of indications: Antibody Recruiting Molecules (ARMs) and Synthetic Antibody Mimics (SyAMs). They believe their technology represents a breakthrough in safer, more efficacious, and more convenient treatment options.
KLEO
Social Links:
Industry:
Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
New Haven, Connecticut, United States
Country:
United States
Website Url:
http://www.kleopharmaceuticals.com
Total Employee:
11+
Status:
Closed
Contact:
(203)428-4596
Email Addresses:
[email protected]
Total Funding:
32 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Liquid Web
Current Advisors List
Current Employees Featured
Founder
Investors List
Biohaven Pharmaceutical
Biohaven Pharmaceutical investment in Series B - Kleo
Peptidream
Peptidream investment in Series B - Kleo
Biohaven Pharmaceutical
Biohaven Pharmaceutical investment in Series A - Kleo
Official Site Inspections
http://www.kleopharmaceuticals.com
- Host name: smtp.waldenponddesign.com
- IP address: 67.225.176.60
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
